Moira McNulty

15PUBLICATIONS
37CO-AUTHORS
PharmacogenomicsAboriginal and Torres Strait Islander medicine and treatmentsGene and molecular therapyPreventative health carePharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 08, 2026
What Do People with HIV Want to Know About Long-Acting Injectable Cabotegravir/Rilpivirine?

|Sep 23, 2026
Satisfaction and Treatment Burden Among Early Adopters of Long-Acting Injectable Cabotegravir-Rilpivirine With and Without Viremia in Three US Ryan White Clinics.

|Mar 12, 2025
Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic.

Geoffroy Liegeon, Christopher Kaperak, Eleanor E Friedman

|Aug 30, 2024
Understanding Opportunities for Prescribing Pre-exposure Prophylaxis (PrEP) at Two Academic Medical Centers in a High Priority Jurisdiction for Ending the HIV Epidemic.

Moira C McNulty, Katherine McGuckin, Eleanor E Friedman

|Jun 10, 2024
Patient Attitudes Toward Self- or Partner-, Friend-, or Family-Administered Long-acting Injectable Antiretroviral Therapy: A Mixed-Methods Study Across 3 Urban Human Immunodeficiency Virus Clinics.

Lauren F Collins, Kimberly A Koester, Moira C McNulty

|Jan 25, 2024
Reflex Human Immunodeficiency Virus (HIV) Type 1 RNA Testing Enables Timely Differentiation of False-Positive Results From Acute HIV Infection.

Christopher Kaperak, Dylan Eller, Samantha A Devlin

Pageof 3

Frequent Collaborators

4 joint publications

Samantha Devlin

2 joint publications

Moctezuma Garcia

2 joint publications

Geoffroy Liegeon

2 joint publications

Katerina A Christopoulos